120 related articles for article (PubMed ID: 11257012)
1. Efficacies of gel formulations containing foscarnet, alone or combined with sodium lauryl sulfate, against establishment and reactivation of latent herpes simplex virus type 1.
Piret J; Lamontagne J; Désormeaux A; Bergeron MG
Antimicrob Agents Chemother; 2001 Apr; 45(4):1030-6. PubMed ID: 11257012
[TBL] [Abstract][Full Text] [Related]
2. Sodium lauryl sulfate increases the efficacy of a topical formulation of foscarnet against herpes simplex virus type 1 cutaneous lesions in mice.
Piret J; Désormeaux A; Cormier H; Lamontagne J; Gourde P; Juhász J; Bergeron MG
Antimicrob Agents Chemother; 2000 Sep; 44(9):2263-70. PubMed ID: 10952566
[TBL] [Abstract][Full Text] [Related]
3. Thermoreversible gel formulations containing sodium lauryl sulfate or n-Lauroylsarcosine as potential topical microbicides against sexually transmitted diseases.
Roy S; Gourde P; Piret J; Désormeaux A; Lamontagne J; Haineault C; Omar RF; Bergeron MG
Antimicrob Agents Chemother; 2001 Jun; 45(6):1671-81. PubMed ID: 11353610
[TBL] [Abstract][Full Text] [Related]
4. Limited efficacy of inhibitors of herpes simplex virus DNA synthesis in murine models of recrudescent disease.
Kristofferson A; Ericson AC; Sohl-Akerlund A; Datema R
J Gen Virol; 1988 Jun; 69 ( Pt 6)():1157-66. PubMed ID: 2838569
[TBL] [Abstract][Full Text] [Related]
5. Correlation between herpes simplex virus type 1 rate of reactivation from latent infection and the number of infected neurons in trigeminal ganglia.
Maggioncalda J; Mehta A; Su YH; Fraser NW; Block TM
Virology; 1996 Nov; 225(1):72-81. PubMed ID: 8918535
[TBL] [Abstract][Full Text] [Related]
6. Combinations of antiviral and anti-inflammatory preparations for the topical treatment of herpes simplex virus assessed using a murine zosteriform infection model.
Awan AR; Harmenberg J; Flink O; Field HJ
Antivir Chem Chemother; 1998 Jan; 9(1):19-24. PubMed ID: 9875373
[TBL] [Abstract][Full Text] [Related]
7. Efficacies of topical formulations of foscarnet and acyclovir and of 5-percent acyclovir ointment (Zovirax) in a murine model of cutaneous herpes simplex virus type 1 infection.
Piret J; Désormeaux A; Gourde P; Juhász J; Bergeron MG
Antimicrob Agents Chemother; 2000 Jan; 44(1):30-8. PubMed ID: 10602719
[TBL] [Abstract][Full Text] [Related]
8. The influence of stress factors on the reactivation of latent herpes simplex virus type 1 in infected mice.
Huang W; Xie P; Xu M; Li P; Zao G
Cell Biochem Biophys; 2011 Sep; 61(1):115-22. PubMed ID: 21327577
[TBL] [Abstract][Full Text] [Related]
9. Bone marrow transplantation in a child with Wiskott-Aldrich syndrome latently infected with acyclovir-resistant (ACV(r)) herpes simplex virus type 1: emergence of foscarnet-resistant virus originating from the ACV(r) virus.
Saijo M; Yasuda Y; Yabe H; Kato S; Suzutani T; De Clercq E; Niikura M; Maeda A; Kurane I; Morikawa S
J Med Virol; 2002 Sep; 68(1):99-104. PubMed ID: 12210436
[TBL] [Abstract][Full Text] [Related]
10. Acyclovir blocks cytokine gene expression in trigeminal ganglia latently infected with herpes simplex virus type 1.
Halford WP; Gebhardt BM; Carr DJ
Virology; 1997 Nov; 238(1):53-63. PubMed ID: 9375008
[TBL] [Abstract][Full Text] [Related]
11. Value of the dorsal cutaneous guinea pig model in selecting topical antiviral formulations for the treatment of recurrent herpes simplex type 1 disease.
Poli G; Dall'Ara P; Binda S; Santus G; Poli A; Cocilovo A; Ponti W
Arzneimittelforschung; 2001; 51(5):433-8. PubMed ID: 11413746
[TBL] [Abstract][Full Text] [Related]
12. Intradermal doxorubicin reduces ganglionic reactivation of latent herpes simplex virus in mice after pretreatment with hypertonic saline.
Sekizawa T; Openshaw H; Itoyama Y
J Med Virol; 2003 Jun; 70(2):263-6. PubMed ID: 12696114
[TBL] [Abstract][Full Text] [Related]
13. Persistent elevated expression of cytokine transcripts in ganglia latently infected with herpes simplex virus in the absence of ganglionic replication or reactivation.
Chen SH; Garber DA; Schaffer PA; Knipe DM; Coen DM
Virology; 2000 Dec; 278(1):207-16. PubMed ID: 11112495
[TBL] [Abstract][Full Text] [Related]
14. Herpes simplex virus type 1 latency in the murine nervous system is associated with oxidative damage to neurons.
Valyi-Nagy T; Olson SJ; Valyi-Nagy K; Montine TJ; Dermody TS
Virology; 2000 Dec; 278(2):309-21. PubMed ID: 11118355
[TBL] [Abstract][Full Text] [Related]
15. Establishment of latent herpes simplex virus type 1 infection in resistant, sensitive, and immunodeficient mouse strains.
Ellison AR; Yang L; Voytek C; Margolis TP
Virology; 2000 Mar; 268(1):17-28. PubMed ID: 10683323
[TBL] [Abstract][Full Text] [Related]
16. Either a CD4(+)or CD8(+)T cell function is sufficient for clearance of infectious virus from trigeminal ganglia and establishment of herpes simplex virus type 1 latency in mice.
Ghiasi H; Perng G; Nesburn AB; Wechsler SL
Microb Pathog; 1999 Dec; 27(6):387-94. PubMed ID: 10588911
[TBL] [Abstract][Full Text] [Related]
17. Importance of the herpes simplex virus UL24 gene for productive ganglionic infection in mice.
Jacobson JG; Chen SH; Cook WJ; Kramer MF; Coen DM
Virology; 1998 Mar; 242(1):161-9. PubMed ID: 9501052
[TBL] [Abstract][Full Text] [Related]
18. A non-consensus branch point plays an important role in determining the stability of the 2-kb LAT intron during acute and latent infections of herpes simplex virus type-1.
Mukerjee R; Kang W; Suri V; Fraser NW
Virology; 2004 Jul; 324(2):340-9. PubMed ID: 15207620
[TBL] [Abstract][Full Text] [Related]
19. Beta interferon plus gamma interferon efficiently reduces acyclovir-resistant herpes simplex virus infection in mice in a T-cell-independent manner.
Huang WY; Su YH; Yao HW; Ling P; Tung YY; Chen SH; Wang X; Chen SH
J Gen Virol; 2010 Mar; 91(Pt 3):591-8. PubMed ID: 19906941
[TBL] [Abstract][Full Text] [Related]
20. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
Itahashi M; Higaki S; Shimomura Y
Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
